ChromaDex Balance Sheet Health
Financial Health criteria checks 6/6
ChromaDex has a total shareholder equity of $28.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $55.0M and $26.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$27.17m |
| Equity | US$28.46m |
| Total liabilities | US$26.51m |
| Total assets | US$54.96m |
Recent financial health updates
We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely
Mar 31
We're Not Very Worried About ChromaDex's (NASDAQ:CDXC) Cash Burn Rate
Mar 03Companies Like ChromaDex (NASDAQ:CDXC) Can Afford To Invest In Growth
Nov 19We Think ChromaDex (NASDAQ:CDXC) Can Easily Afford To Drive Business Growth
May 14Recent updates
Should You Think About Buying ChromaDex Corporation (NASDAQ:CDXC) Now?
Apr 05Not Many Are Piling Into ChromaDex Corporation (NASDAQ:CDXC) Just Yet
Feb 28ChromaDex Corporation's (NASDAQ:CDXC) Intrinsic Value Is Potentially 85% Above Its Share Price
Jan 29Market Cool On ChromaDex Corporation's (NASDAQ:CDXC) Revenues
Jun 08We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely
Mar 31ChromaDex inks new commercial supply agreement for its Niagen ingredient with Nestlé
Oct 11ChromaDex forms JV in Asia for Tru Niagen; plans to raise $3.1M via stock sale
Oct 03ChromaDex in pact to introduce anti-aging compound in Brazil
Sep 01Ayana Bio appoints Frank Jaksch as CEO
Aug 24ChromaDex wins patent challenge as US regulator rejects Thorne Research's demand to invalidate patent
Aug 15Some ChromaDex Corporation (NASDAQ:CDXC) Analysts Just Made A Major Cut To Next Year's Estimates
Mar 15We're Not Very Worried About ChromaDex's (NASDAQ:CDXC) Cash Burn Rate
Mar 03Companies Like ChromaDex (NASDAQ:CDXC) Can Afford To Invest In Growth
Nov 19When Should You Buy ChromaDex Corporation (NASDAQ:CDXC)?
Sep 14We Discuss Whether ChromaDex Corporation's (NASDAQ:CDXC) CEO Is Due For A Pay Rise
Jun 11ChromaDex to sell Tru Niagen in 3,800 Walmart stores in the U.S.
Jun 07Is There Now An Opportunity In ChromaDex Corporation (NASDAQ:CDXC)?
Jun 02We Think ChromaDex (NASDAQ:CDXC) Can Easily Afford To Drive Business Growth
May 14Financial Position Analysis
Short Term Liabilities: CDXC's short term assets ($49.5M) exceed its short term liabilities ($20.6M).
Long Term Liabilities: CDXC's short term assets ($49.5M) exceed its long term liabilities ($5.9M).
Debt to Equity History and Analysis
Debt Level: CDXC is debt free.
Reducing Debt: CDXC had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CDXC has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CDXC is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 18.4% per year.